Drugs / SUN-131
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT02338648 | Oct 2014 → Jan 2016 | chalazion | Senju USA, Inc. | Completed | No outcome recorded |
| Phase 31 trial · 1 missed | ||||||
| Phase 3 | NCT03248440 | Jul 2017 → Aug 2018 | chalazion | Senju USA, Inc. | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SUN 131 | “Safety and Efficacy Study of SUN 131 TDS as Compared to Placebo TDS in Adult Patients With a Chalazion” NCT02338648 ↗ |
| Route | Other | “local delivery of a corticosteroid, to the upper or lower eyelid” NCT03248440 ↗ |